Cell-based therapies are promising treatments for various kidney diseases. However, the major hurdle in initiating therapeutic responses is the inefficiency of injection routes to deliver cells to the kidney parenchyma. Systemic injection, such as intravenous injection only delivers a small proportion of cells to the kidney. Whereas direct delivery, such as renal artery injection require surgical procedures. A minimally invasive renal artery injection was therefore developed to enhance cell delivery to kidney. In this study, luciferase expressing human adipocyte derived stem cells (ADSC) were labelled with gold nanorods (GNR) and injected into the renal artery using ultrasound guidance. The ADSCs were tracked using bioluminescence and photoacoustic imaging serially over 7 days. Imaging confirmed that the majority of signal was within the kidney, indicative of successful injection and that signal remained stable for 3 days. Histology showed co-localization of GNRs with ADSC staining throughout the kidney with no indication of injury caused by injection. These findings demonstrate that ultrasound-guided renal artery injection is feasible in mice and can successfully deliver a large proportion of cells which are retained within the kidney for 3 days.
Introduction
Over the past few years, stem cell-based regenerative therapy has been vastly studied as an alternative treatment for various kidney diseases. Mesenchymal stem cells (MSCs) have been used to repair kidney damage due to their ability to release a variety of active biological factors including growth factors such as insulin-like factor 1 (IGF-1) 1 , vascular endothelial growth factor (VEGF) 2 , and other immune system signalling molecules, such as, transforming growth factor-β (TGF-β) 3 . Through these signalling cascades, MSCs are able to recruit and promote repair processes during acute kidney injury (AKI). Therefore, MSC-based therapy has been tested in several AKI mouse models and has been used to treat patients with AKI in three clinical trials 4 .
Although many studies have demonstrated the efficacy of stem cell therapy in kidney diseases, the engraftment of stem cells within the kidney parenchyma as a routine clinical treatment is hindered by the inefficient delivery and retention of stem cells after transplantation. Intravenous (IV), intra-arterial and intraparenchymal injections have been tested in many mouse models of AKI to deliver MSCs to kidney. Although IV injection is a relatively easy and non-invasive method of administration, the main problem is the pulmonary entrapment of cells directly after injection which thereby reduces engraftment within the kidney 5 . Several studies have shown that systemic intra-arterial delivery which by-passes the lung can provide increased cell retention in kidney 6, 7 . However, evidence of vascular occlusion after intra-arterial injection has been reported which raises safety concerns 8 . A study by Alfarano et al., directly injected cells into the renal parenchyma which resulted in reduced kidney fibrosis in a rat model of renal ischemia-reperfusion 9 but this approach is difficult to implement in a clinical setting due to the risk of additional injury. Similarly, the delivery of MSCs directly into the renal artery of an injured kidney has been shown to increase cell engraftment in preclinical studies 10, 11 . However, this method is invasive and is usually conducted at the end of the open abdominal surgery to induce renal ischemia. Therefore, the development of a less invasive and more efficient injection route is urgently required to improve stem cell delivery to preclinical kidney injury models.
In addition to establishing the optimal route for stem cell delivery, tracking of transplanted cells and verifying their viability within the target organ is equally important in determining therapeutic efficacy of the cell therapy. Nuclear imaging using 111
In-oxine labelling has been used to track stem cells in a mouse model of renal ischemia-reperfusion injury 12 . However, due to its low spatial resolution, it lacks detailed information on cell localisation. Iron oxide particles are one of the most widely used MRI-based cell tracking agents for locating transplanted cells in kidney 10, 13, 14 . Although MRI can provide excellent spatial resolution, iron oxide particles produce negative contrast which makes it difficult to quantify the number of cells in kidney. In addition, the presence of iron oxide particles will interfere with potential functional MRI assessments utilized for kidney diseases such as blood flow measurements. 15 Despite many studies having explored the applicability of various fluorescent probes, such as near infrared dyes for stem cell tracking in kidney 16, 17 , the utility of optical imaging is limited owing to light scattering which reduces the spatial resolution and penetration depth.
Compared to current imaging modalities, photoacoustic (PA) imaging is a relatively new but rapidly expanding non-invasive medical imaging field. It is a combined technology of ultrasound and optical imaging. The mechanism of PA is based on the detection of light absorption in ultrasound (acoustic) wave form generated by laser excited chromophores within tissue, for example, haemoglobin. Since acoustic waves are not scattered as much as light photons, the advantages of PA are deeper tissue penetration and better spatial resolution than optical imaging. A previous study has demonstrated the great potential of PA as a cell tracking tool by using a tyrosinase-based genetic reporter
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. However, the production of melanin from this reporter gene can be cytotoxic to some cell types and therefore may not be suitable for stem cell tracking 19 . Therefore, to use PA imaging in tracking cell therapies, the contrast agents need to have minimal cytotoxicity with little interference in the cell's biological functions.
Since gold is known to be non-cytotoxic and inert in biological environment, gold nanoparticles have been extensively used in vitro cell imaging 20 . Gold nanoparticles are also promising PA contrast agents due to their unique optical properties which allow optical absorption in the near infrared window where background tissue absorbance is minimal. In addition, the sensitivity of PA imaging can be improved by modifying the shapes of gold nanoparticles such as gold nanorods (GNRs) because of their tunable optical wavelength which results from surface plasmon resonance 21 . Moreover, unlike iron oxide nanoparticles, GNRs do not impede any functional assessment of the target organ by MRI. For these reasons, GNRs have been successfully applied as stem cell tracking agents for PA imaging 22 . As many studies have showed the advantages of PA imaging in detecting kidney disease such as ischemic kidney damage 23 , early kidney injury 24 , Adriamycin-induced nephropathy 25 and polycystic kidney diseases 26 , tracking GNRs labelled MSCs in kidney with PA imaging will provide accurate cell localisation which corresponds to the structural and functional status of the kidney.
In this study, a novel non-surgical ultrasound-guided renal artery injection was developed to improve stem cell delivery to the kidney without the need for open abdominal surgery. In addition, a dual bioluminescence imaging (BLI) and PA imaging approach was applied in this study by labelling luciferase expressing ADSCs with GNRs. This allowed for the visualisation of cell viability (BLI) with cell localisation within the kidney serially over time after ultrasoundguided renal artery injection.
Result

Intracellular uptake of GNRs and their effect on cell proliferation and differentiation potential
Internalisation of GNRs by ADSCs was visualised under a light microscope using sliver enhancement staining which showed the presence of dark aggregates inside the cytoplasm of ADSCs compared to control (Figure 1a & b) . The effect on cell proliferation of ADSCs after GNR labelling was studied by measuring bioluminescence emission as a surrogate measurement of cell proliferation. There were no differences in signal intensity between control and GNR labelled groups which showed an increase in signal from day 1 to day 3 after plating which remained stable throughout the study (Figure 1c) . The effect on tri-lineage (adipogenic, chondrogenic and osteogenic) differentiation potential of ADSCs after GNR labelling was assessed by performing differentiation assays (Figure 2) . The results showed both the control and GNR labelled cells could differentiate towards tri-lineages at a similar rate. These results indicate that GNR labelling has no adverse effect on cell proliferation and differentiation potential of ADSCs.
Stem cell delivery to kidney via ultrasound-guided renal artery injection
Ultrasound-guided renal artery injection was performed using 6-8-week-old female nude mice. were suspended in 100 μl of 0.6% alginate solution and injected slowly into the renal artery using a 1 ml syringe with a 29 g needle. In order to avoid surrounding organs damage, the needle was penetrated into the renal artery by passing through paravertebral muscle ( Figure   3e ). Successful injection was visualised by the presence of hyperechogenic contrast from the alginate solution around the renal cortex (Figure 3f ). The needle was slowly withdrawn from the body and a colour Doppler image was acquired to assess blood flow to the kidney. The heart rate, body temperature and respiration rate were monitored during the injection and imaging of the kidney which took approximately 15 minutes. The animals were then recovered from anaesthesia and no significant weight loss or sign of major trauma was observed as monitored by body weight and colour of the urine throughout the study.
Assessment of the cell viability and cell localisation following renal artery injection
To assess the viability and localisation of GNR labelled ADSCs within the kidney, the mice were imaged with BLI and photoacoustic imaging serially for 7 days after ultrasound-guided right renal artery injection. Ex vivo BLI was performed at 1 hour and day 8 after injection to validate in vivo results. 
Histological analysis
In order to validate the presence of GNR labelled ADSCs in the right kidney after renal artery injection, the kidney sections from day 8 after injection were stained with human specific vimentin (ADSCs) and sliver enhancement (GNRs) using the left kidney as control tissue Observation of the pathology of right kidney showed no signs of trauma or haemorrhage resulting from the injection and no malignant tumour formation that could potentially result from ADSC engraftment.
Discussion
The aims of this study was to improve stem cell delivery to preclinical kidney models by developing a minimally invasive ultrasound-guided renal artery injection and to subsequently assess the viability and localisation of delivered cells by serial imaging by BLI and PA over seven days.
The intracellular uptake of GNRs by ADSCs was studied and the results showed that GNRs were internalised inside the cytoplasm. These results are consistent with studies carried out known to be viscus 27 and commonly used in ultrasound contrast agents 28 , the re-suspension medium was changed to 0.6% alginate solution to prevent spillage and to improve the accuracy of the injection by taking advantage of the ultrasound contrast provided by alginate.
The distribution of GNR labelled cells in the kidney after injection was assessed by using BLI and PA imaging. At 1 hour after injection, although the majority of the signal (29 ± 6%) was detected in the injected right kidney, there was some signal from the lungs in BLI images. This is most likely due to leakage of cells into the renal vein which is situated alongside the renal artery during the injection. Therefore, it is likely that the cells are transported to the lungs via venous drainage from the right ventricle as the blood from the renal vein drains into the inferior vena cava and then into the right atrium. Interestingly, BLI signal from the lungs decreased from day 1 after injection and was not detectable at day 7 while the percentage BLI signal in right kidney significantly increased at days 1 and 3 after injection. In comparison, many studies have reported the persistence of BLI signal within the lungs for 7 days after IV injection 7, 29 . This is likely due to differences in the number of cells entrapped in the lung capillaries compared to the kidney.
More importantly, both BLI and PA images at the early time points suggested that the ultrasound-guided renal artery injection was successful and that the majority of the GNR labelled cells were retained within the right kidney and remained viable for 3 days. In addition, the widespread cell distribution across the kidney, including the cortex and medulla was detected in PA images and further confirmed by histological analysis. These results highlight the advantages of using PA imaging which can provide the high spatial resolution of cell localisation in the kidney.
Although consistent findings were seen between BLI and PA images at early time points, discrepancies were observed at day 7 after injection. Since BLI is a reporter gene-based cell tracking method that requires ATP, the signal generation depends on cell survival, while in PA imaging, the presence of signal only represents the existence of the direct labelling agent, GNR, not the cell itself. Therefore, if GNRs remain within the cell after cell death then the PA signal remains even when BLI decreases. These results consequently suggest that only a small number of cells remain viable 7 days after injection but the majority of dead cells are retained within the kidney. Nonetheless, these studies were done in mice with no underlying kidney disease and therefore the length of cell viability could be altered in disease state.
PA images were taken at different wavelengths to discern signal from the vasculature (600 nm) to that of GNR labelled cells (730 nm). Although the highest PA signal within the right kidney was at 730 nm without spectral unmixing it is unclear if some underlying signal came from haemorrhage. However histological findings at day 8 after injection confirmed the widespread presence of GNR labelled ADSCs throughout the kidney with no evidence of haemorrhage or injury derived from the injection of ADSCs and mice showed no evidence of blood within the urine at any point. Although histology also showed no signs of tumour formation there are still safety concerns regarding MSC-based therapies in kidney diseases.
In addition, the maldifferentiation of MSC into glomerular adipocytes and sclerosis after renal artery injection have been reported in a rat model of renal failure 30 . Therefore, more studies are required to investigate the long term fate of MSCs in recipient's organ after transplantation.
In summary, the results presented in this study demonstrated the successful development of a minimally invasive ultrasound-guided renal artery injection which can improve stem cell delivery to the kidney. In addition, the findings from this study displayed the benefits of combining a reporter gene (luciferase, BLI) with a direct cell labelling method (GNR, PA) which can provide both cell viability and cell localisation in the target organ. The new techniques which have been developed in this study can be applied to track other stem cell types such as kidney derived stem or progenitor cells. The information acquired from this study will can therefore be applied to the optimisation of cell therapies in various rodent models of kidney diseases such as acute kidney injury.
Materials and methods
All chemical materials were from Sigma-Aldrich (Dorset, UK), unless otherwise stated.
Gold nanorods (GNRs)
All experiments were performed using silica coated GNRs which were kindly provided by Dr 
Cell culture
All experiments were performed using human adipose derived stem cells (ADSCs) which were kindly provided by Dr Michelle Griffin, UCL Plastic and Reconstructive Surgery Department.
ADSCs were transduced with a lentiviral vector using plasmid pSEW 31 . After washing 3 times with PBS, the labelled ADSCs were trypsinised, centrifuged for pelleting at 300 g, counted and then plated for in vitro studies or re-suspended in 0.6% alginate solution for in vivo cell injection.
Silver enhancement staining
To visualise intracellular GNR uptake by ADSCs, silver enhancement staining was performed according to manufacturer's instructions (silver enhancer kit, Sigma-Aldrich, St Louis, USA).
GNR labelled ADSCs were plated in 24-well plates at a concentration of 0.22 x 10 5 per well in triplicates and left to attach overnight. Next, the well plates were washed 3 times with PBS and the cells were fixed in 4% PFA for 30 minutes at room temperature. The cells were then washed 2 times with PBS followed by staining with silver enhancer mixture for 10 minutes at 20 ºC. The cells were then washed 2 times with distilled water and fixed with 2.5% sodium thiosulfate solution for 3 minutes. Fixative was removed by washing 3 times with distilled water and the cells were counterstained with 1% Nuclear Fast Red and then imaged with EVOS FL Auto cell imaging system.
In vitro luciferase assay
For luciferase-based cell proliferation assay, control ADSCs and GNR labelled ADSCs were plated in 96-well plates at a concentration of 5 x 10 3 per well in triplicates. In vitro luciferase assay was performed using a Varioskan LUX multimode microplate reader (ThermoFisher Scientific, Waltham, MA USA) at days 1, 2, 3, 6 and 9 after plating. The measurements were acquired immediately after adding 300 μg/ml of D-luciferin and the results were presented as luminescence.
Differentiation assay
To determine the effect of labelling on the differentiation potential of ADSCs, a differentiation assay was performed as previously described 33 . Control and GNR labelled ADSCs were plated in 24-well plates (Corning) at a concentration of 0.22 x 10 5 per well in triplicates. When both control and labelled cells reached 90-100% confluency, the regular media was removed and differentiation media (adipogenic, chondrogenic or osteogenic) was added to appropriate wells and was changed every three days. Undifferentiated wells received regular media. After 3 weeks staining was conducted for each differentiation and the cells were imaged using the EVOS FL Auto cell imaging system.
Adipogenic differentiation
Adipogenic differentiation was induced with DMEM-F12 medium containing 10% FCS, 1%
penicillin/streptomycin, 10 ng/ml insulin, 1 μM dexamethasone, 500 µM 3-isobutyl-1-methylxanthine and 1 mM rosiglitazone. After 3 weeks, cells were fixed in 10% formalin for 30 minutes, washed with deionised water and then washed again with 60% isopropanol for 5 minutes prior to staining with Oil Red O working solution for 10 minutes. After staining, cells
were washed several times with tap water.
Chondrogenic differentiation
Chondrogenic differentiation was induced with DMEM-F12 medium containing 10% FCS, 1%
penicillin/streptomycin, 0.1 μM dexamethasone, 50 μg/ml ascorbate, 10 ng/ml transforming growth factor (TGF) β1 (Life technologies, Paisley, UK) and 10 ng/ml insulin, transferrin, 
In vivo cell injections
Mice were imaged and injected using a VEVO 2100 ultrasound imaging system (VEVO 2100, FUJIFILM VisualSonics, Canada) with a Visualsonics ultrasound platform and injection rig.
Mice were secured in the left lateral position with tape with their heart rate, body temperature and respiration rate monitored throughout the procedure. 
PA imaging
Directly after BLI imaging, mice were anaesthetised and PA scans were acquired at 3-5 hour after injection (termed day 0), and then at days 3 and 7 using a planar PA scanner (built in the Department of Medical Physics and Biomedical Engineering, UCL) based on a Fabry-Pérot (FP) polymer film ultrasound sensor and a tunable oscillator laser system (Quanta Ray Pro-270/premiScan; Newport Spectra Physics/GWU Lasertechnik). The PA images of right and left kidneys were acquired as previous described in Ogunldade et al., 2018 26 . In brief, the animals were placed in a supine position and a small amount of ultrasound gel was applied to the lower back of the animals. Laser light pulses were excited onto tissue at 7 ns with a pulse repetition frequency of 50 Hz. Photoacoustic signals were produced and detected by the FP ultrasound sensor using four different wavelengths between 600-900 nm (600, 730, 800 and 900 nm) to differentiate between signal derived from haemoglobin and that from GNR (however, spectral unmixing was not performed in this instance). An integrated heater and thermal chamber with temperature set to 34 ºC was used during the imaging to maintain core body temperature. The images were displayed as MIPs and 3D volume-rendered images.
False colouring, manual segmentation and extracting of the vasculature architecture was performed using Amira (FEI Visualization Sciences).
Ex vivo BLI imaging
Ex vivo BLI was performed at 1 hour and day 8 after renal artery injection. Under anaesthesia, mice were injected intraperitoneally with 75 mg/kg D-luciferin. At 10 minutes after injection, mice were sacrificed and the organs of interest were excised quickly and images were acquired using 5 minutes exposure time and binning 8.
Histology and immunohistochemistry (IHC)
At day 8 after renal artery injection, right and left kidneys were excised, fixed in 10% neutral buffered formalin and embedded in paraffin. Human specific vimentin (CONFIRM™ antiVimentin (V9) primary mouse monoclonal antibody, Roche) staining was performed on 5 μm kidney tissue sections to detect the presence of ADSCs using Ventana Discovery XT instrument and Ventana Red detection kit. For pre-treatment, Ventana CC1, equivalent to EDTA buffer, was used. To demonstrate the presence of GNRs, IHC stained sections were stained with silver enhancement staining (silver enhancer kit, Sigma-Aldrich, St Louis, USA)
according to manufacturer's instructions.
Statistical analysis
All in vitro experiments were repeated at least 3 times with 3 triplicates.
Statistical analysis was performed with GraphPad Prism version 6.01. Data were presented as mean ± standard deviation (SD). Unpaired two-tailed t test was conducted for the assessment of statistical significance. 
